AWARD OUTCOME
What happened
University Hospitals Sussex NHS Foundation Trust published contract details for direct, below-threshold procurement of T-SPOT testing for latent TB. The published contract record names OXFORD IMMUNOTEC LIMITED a Revvity Company as supplier.
Published outcomeAward 1 is active and is linked to active contract 1. The source explicitly records a signed date of 1 January 2026 and a contract period from 1 January 2026 to 31 March 2027.
Market significanceThis is a £86,770 gross NHS diagnostic-testing services contract awarded without competition below the relevant threshold.
AWARDED SUPPLIERS AND LOTS
1 supplier record analysed
OXFORD IMMUNOTEC LIMITED a Revvity Company
96% confidenceAward 1 · Lots 1 · £86,770 gross (contract-level value; sole named supplier and sole lot) GBP · Active award and active contract
View supporting evidence
Award 1 names OXFORD IMMUNOTEC LIMITED a Revvity Company as its sole supplier and relates to lot 1. Contract 1, linked to award 1, has a gross value of GBP 86,770.
LIFECYCLE
Award or contract stage
Notice type
99% confidenceContract details notice on Find a Tender
View supporting evidence
Process and contract document metadata identify the notice as a Contract details notice on Find a Tender.
Procurement status
98% confidenceComplete
View supporting evidence
The process and sole lot are marked complete in the source data.
Award status
99% confidenceActive
View supporting evidence
Award 1 has status active.
Contract status
99% confidenceActive
View supporting evidence
Contract 1 has status active.
Contract signature recorded
99% confidence1 January 2026
View supporting evidence
Contract 1 dateSigned is 2026-01-01T00:00:00Z.
VALUES
Published values explained
Contract value
99% confidence£86,770 gross
View supporting evidence
Contract 1 value records amountGross 86770 and currency GBP.
Value allocation
93% confidenceContract-level value linked to award 1; no separate lot value published
View supporting evidence
The contract is linked to award 1, which has one supplier and relates to sole lot 1; the lot record has no value.
TIMELINE
Procurement timeline
Contract signed
99% confidence1 January 2026
View supporting evidence
Contract 1 dateSigned is 2026-01-01T00:00:00Z.
Contract start
99% confidence1 January 2026
View supporting evidence
Contract 1 period startDate is 2026-01-01T00:00:00Z.
Contract end
99% confidence31 March 2027
View supporting evidence
Contract 1 period endDate is 2027-03-31T23:59:59+01:00.
Initial notice publication
99% confidence19 October 2026
View supporting evidence
The contract document and process publication timestamp are 2026-10-19T11:08:38+01:00.
Later source update
96% confidence19 October 2026
View supporting evidence
Release history records contract and award updates at 2026-10-19T11:42:12+01:00.
SCOPE
What was awarded
Requirement
99% confidenceT-SPOT testing for latent tuberculosis (TB)
View supporting evidence
The process description states: Procurement of T-SPOT testing for latent TB.
Procurement category
99% confidenceServices
View supporting evidence
Award 1 mainProcurementCategory is services.
CPV classification
99% confidence85111810 — Blood analysis services
View supporting evidence
Award item 1 carries CPV 85111810, described as Blood analysis services.
Lot structure
98% confidenceOne lot (lot 1); no lot title or description published
View supporting evidence
The tender has one lot, id 1, and award 1 relates to it; its title and description are null.
PROCEDURE
Procedure and competition
Procurement method
99% confidenceDirect
View supporting evidence
The process and tender procurementMethod are direct.
Competition basis
99% confidenceBelow threshold — without competition
View supporting evidence
The published procurementMethodDetails state Below threshold - without competition.
Tender submissions
99% confidenceUnknown
View supporting evidence
Information not supplied in the published notice.
Evaluation and award rationale
99% confidenceUnknown
View supporting evidence
Information not supplied in the published notice.
CONTRACT TERMS
Published contract terms
Contract period
99% confidence1 January 2026 to 31 March 2027
View supporting evidence
Contract 1 period records these start and end dates.
Duration
94% confidenceApproximately 15 months
View supporting evidence
Calculated from the explicit contract period of 1 January 2026 to 31 March 2027.
Extension or renewal options
99% confidenceUnknown
View supporting evidence
Information not supplied in the published notice.
Above-threshold status
99% confidenceNo
View supporting evidence
Contract 1 aboveThreshold is false.
COMMERCIAL VIEW
Commercial observations
Route-to-market signal
99% confidenceThe buyer used a direct, below-threshold route without competition.
View supporting evidence
Published procurement method details state Below threshold - without competition.
Addressable requirement
98% confidenceLatent TB testing, classified as blood analysis services.
View supporting evidence
The description specifies T-SPOT testing for latent TB and the award item is classified as CPV 85111810.
Published commercial scale
99% confidence£86,770 gross over the stated contract period.
View supporting evidence
Contract 1 records a gross value of GBP 86,770 and runs from 1 January 2026 to 31 March 2027.
DATA QUALITY
Gaps and source limitations
Publication timing anomaly
99% confidenceThe notice was published after the recorded signature and start dates.
View supporting evidence
The contract is recorded as signed and started on 1 January 2026, while the notice was published on 19 October 2026.
Supplier legal-identity verification
99% confidenceNo separate verified company name or company number was supplied.
View supporting evidence
Supplier verification is marked not_applicable; verified_company_name and verified_company_number are null.
Lot detail
99% confidenceLot 1 has no published title, description or separate value.
View supporting evidence
Lot 1 fields for title, description and value are null.
Competition and evaluation detail
99% confidenceBid count, scoring and rationale are not published.
View supporting evidence
Information not supplied in the published notice.
SOURCE DATA LIMITATIONS
Information not supplied in the published notice
- No separate verified legal company name or company number is supplied for the named supplier; the analysis uses the source-provided supplier name.
- The source records publication on 19 October 2026, after the stated contract signature and start date of 1 January 2026.
- No tender deadline, submission count, evaluation detail, award rationale or pricing breakdown is published.
- Lot 1 has no published title, description or individual value.
- No extension or renewal terms are published.
MARKET THEMES
Relevant award themes
University Hospitals Sussex NHS Foundation TrustOxford ImmunotecT-SPOT testinglatent TB testingblood analysis servicesNHS procurementFind a Tender
COMMON QUESTIONS
About this award
Who was named as supplier for the latent TB testing contract?
The published award names OXFORD IMMUNOTEC LIMITED a Revvity Company.
What is the contract value?
The published contract value is £86,770 gross.
When does the contract run?
The published period is from 1 January 2026 to 31 March 2027.
Was the procurement competed?
The notice states that it was a direct, below-threshold procurement without competition.
ProcuraAxis award analysis supplements, but does not replace, the official award notice, contract data or procurement documents. “Awarded” does not by itself prove that a contract has been signed.